Mahler, Donald A <br/><br/>
Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate.  [electronic resource] 

 -  Journal of aerosol medicine and pulmonary drug delivery  Apr 2014 
 - 103-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1941-2703 
<br/><br/><label>Standard No.: </label>10.1089/jamp.2013.1038  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adrenergic beta-2 Receptor Agonists--administration & dosage<br/>Aerosols<br/>Aged<br/>Aged, 80 and over<br/>Albuterol--administration & dosage<br/>Bronchodilator Agents--administration & dosage<br/>Cross-Over Studies<br/>Drug Delivery Systems--instrumentation<br/>Ethanolamines--administration & dosage<br/>Female<br/>Forced Expiratory Volume<br/>Formoterol Fumarate<br/>Humans<br/>Inhalation--drug effects<br/>Lung--drug effects<br/>Male<br/>Middle Aged<br/>Nebulizers and Vaporizers<br/>New Hampshire<br/>Patient Preference<br/>Powders<br/>Prospective Studies<br/>Pulmonary Disease, Chronic Obstructive--diagnosis<br/>Salmeterol Xinafoate<br/>Single-Blind Method<br/>Time Factors<br/>Treatment Outcome<br/>Vital Capacity